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PolymorphismsThe innate immune system represents the ﬁrst line of host defense against pathogens. Genetics factors
regulating the immune responses play a role in the susceptibility to infectious diseases, such as tubercu-
losis (TB). We analyzedMBL2 promoter and exon 1 functional single nucleotide polymorphisms (SNPs) in
a group of 155 TB patients and 148 healthy controls in order to evaluate their inﬂuence on the onset of
infection and TB development. There was no association between MBL2 550 HL promoter polymor-
phisms and susceptibility to develop TB, but heterozygous 221 Y/X genotype was signiﬁcantly more fre-
quent in pulmonary TB patients than controls. Moreover, MBL2 exon 1 O allele, was signiﬁcantly
associated with susceptibility to TB development in general (p = 0.023, OR = 1.61, 95% CI 1.05–2.49)
and pulmonary TB (p = 0.0008, OR = 2.16, 95% CI 1.35–3.46); C allele at codon 57, as well as A/C genotype,
were signiﬁcantly more frequent in TB patients than in controls. Our results indicate thatMBL2 polymor-
phisms, especially at codon 57, could be considered as risk factors for TB development.
 2013 Elsevier B.V. All rights reserved.1. Introduction
Among all the infectious diseases affecting humans, tuberculo-
sis (TB) caused by Mycobacterium tuberculosis remains one of the
most lethal (WHO, 2011). Based on tuberculin test, epidemiologists
estimate that one-third of the world population (2.2 billion people)
is infected with the bacillus (Ducati et al., 2006). In Brazil, 80,000
cases are registered annually with incidence rate of 37.1/1,00,000
inhabitants, according to data from the Brazilian Health Ministry
(Brazil, 2008).
The risk of infected individuals to develop the active form of the
disease during their lifetime ranges between 5% and 10%. In these
individuals, the chances of illness depend on the immune system’s
ability to prevent the multiplication of dormant M. tuberculosis
(Oliveira et al., 2004).
Innate immunity is the ﬁrst line of host defense. At some time in
the cycle of TB infection, most infected humans, who are immuno-
competent, will show the presence of the mycobacteria and beginto generate an immune response, destroying macrophages con-
taining bacilli. This process will result in the presentation of myco-
bacterial antigens to the host immune system, leading to the
generation of a speciﬁc immune response against M. tuberculosis
(Clark-Curtiss and Haydel, 2003; Ducati et al., 2006).
Previous studies have demonstrated the association of several
genes with the susceptibility to TB, such as human leukocyte anti-
gen (HLA), natural resistance-associated macrophage protein 1
(NRAMP1), vitamin D receptor (VDR), interleukin-1 (IL1), interleu-
kin-12B and interleukin-12 receptor (IL-12Rb1) (Singh et al.,
1983; Bellamy et al., 1998, 1999; Goldfeld et al., 1998; Greenwood
et al., 2000; Wilkinson et al., 2000; Remus et al., 2004; Morris et al.,
2011). A linkage analysis on sib-pairs conducted in Africa (Bellamy
et al., 2000) has mapped TB susceptibility loci at chromosomes
15q11–13 and Xq26, although another genome-wide scan,
performed in the north of Brazil, did not replicate those ﬁndings
(Miller et al., 2004).
Certain innate immunity proteins, such as the mannose binding
lectin (MBL), can recognize the mannose on pathogens’ surface,
promoting both the opsonization and activation of the comple-
ment system. MBL deﬁciency has been associated with an
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gillosis, meningococcal disease and invasive pneumococcal
infections.
In TB context, the role of MBL is controversial. Some studies
showed that MBL deﬁciency protects against TB (Garcia-Laorden
et al., 2006; Cosar et al., 2008; Denholm et al., 2010; Liu et al.,
2010); on other hand, MBL deﬁciency was also associated with sus-
ceptibility to TB infection (Selvaraj et al., 2006; Alagarasu et al.,
2007; Capparelli et al., 2009).
Mbl2 gene (10q11.2-q21) encodes for the mannose binding lec-
tin and presents several polymorphisms, six of which are known
for their functional effect. Three are located at exon 1: the ﬁrst
one, rs5030737 is a C>T transition at codons 52 (CGT>TGT) that re-
sults in Arg52Cys substitution (where the variant allele is also
known as ‘‘D’’ allele), rs1800450 is a G>A transition (known as
‘‘B’’ allele) at codons 54 (GGC>GAC) resulting in Gly54Asp substitu-
tion, and rs1800451 is a G>A transition (known as ‘‘C’’ allele) at co-
don 57 (GGA>GAA) resulting in Gly57Glu substitution. (Madsen
et al., 1994), These SNPs together are identiﬁed as ‘‘AO’’ polymor-
phisms, were the ‘‘A’’ wild-type allele, indicate no variant alleles
at codons 52, 54 and 57 (C, G and G nucleotide respectively) and
the ‘‘O’’ mutant allele, indicate the presence of one or more mutant
alleles in either codons 52, 54 and 57 (T, A and A nucleotide,
respectively). The presence of a O allele, in heterozygosis correlate
with low levels of functional protein in the serum, and in homozy-
gosis with almost undetectable MBL levels in both healthy individ-
uals and patients affected by various diseases (Madsen et al., 1994;
Wallis, 2003).
Mbl2 variants are quite frequent, although unevenly distributed
in human populations (Garred et al., 2006; Thye et al., 2011). Allele
‘‘B’’ is extremely rare in West Africa but occurs at frequencies of
0.14 (Caucasians), 0.25 (Asians) and 0.50 (indigenous South Amer-
icans). On the other hand, the ‘‘C’’ allele is rare among Caucasians
but common in sub-Saharan Africa. The ‘‘D’’ allele in general is
rather uncommon and largely restricted to North Africans and Cau-
casians. The high frequencies of these alleles in certain populations
suggested that functional MBL deﬁciencies might confer some bio-
logical advantage (Bernig et al., 2004).
In addition to exon 1 polymorphisms, there are three SNPs in
MBL2 gene promoter region, namely 550C>G (rs11003125, also
known as ‘‘HL’’ variant, where L is the wild type allele), 221G>C
(rs7096206, ‘‘XY’’ variant, where Y is the wild type allele) and
+4C>T (rs7095891, ‘‘PQ’’ variant, where P is the wild type allele),
that can inﬂuence transcription rate and consequently the concen-
tration of serum MBL. SNPs in exon 1 are in strong linkage disequi-
librium with the ones located at the promoter region, originating
seven common haplotypes (HYPA, LYQA, LYPA, LXPA, LYPO, LYQO
and HYPO) showing considerable variation in their frequencies
among different ethnic groups (Steffensen et al., 2000).
This study aims to examine whetherMBL2 gene polymorphisms
are associated with the occurrence of active tuberculosis, in a Bra-
zilian population from the state of Pernambuco, Northeast of Bra-
zil, in order to evaluate their possible inﬂuence on disease onset.2. Material and methods
2.1. Study population
The study population comprises 155 patients (101 males and 54
females, mean age 29.83 ± 16.14) from the ‘‘Hospital das Clínicas –
Universidade Federal de Pernambuco’’ (HC–UFPE), ‘‘Instituto de
Medicina Integral Professor Fernando Figueira’’ (IMIP), ‘‘Hospital
Barão de Lucena’’ (HBL/SUS) and ‘‘Hospital Otávio de Freitas’’
(HOF/SUS), all located at metropolitan area of Recife, Pernambuco,
Brazil.This group was composed of 119 pulmonary TB (84 males and
35 females, mean age 28 years ± 10.4) and 36 extra-pulmonary
tuberculosis patients (17 males and 19 females. mean age
31 years ± 16.9). The diagnosis was based on clinical symptoms
and radiographic ﬁndings, along with bacteriological conﬁrmation
(culture, smear and/or polymerase chain reaction) as described by
the American Thoracic Society (2000).
As control group, we enrolled 148 healthy individuals (81 fe-
males, 67 males; mean age 25 years ± 2.42), unrelated to patients,
with negative Mantoux test, showing no symptoms of tuberculosis
or previous history of the disease. All patients and control subjects
were matched for ethnicity, HIV-negative and not under immuno-
suppressive medication. We tried to choose the best controls in
terms of similarity of exposition to TB patients, by enrolling
healthy individuals from the same areas (metropolitan Recife, Per-
nambuco, Brazil), where patients have been collected. HIV infec-
tion was exclusion criteria when enrolling TB patients, since
MBL2 polymorphisms, being also related with susceptibility to
HIV infection, could represent a confounding factor.
Written and informed consent was obtained form the patients
or their parents (in case of minor age) and the CPqAM/FIOCRUZ
Ethics Committee (CEP Registration – 55/05) approved the study.
Patients underwent a standardized clinical-epidemiological ques-
tionnaire. Data were stored and subsequently processed using
the Statistical Package for Social Sciences (SPSS – version 10.0 for
Windows).2.2. MBL2 genotyping
Genomic DNA was extracted from whole blood using QIAamp
DNA Blood Kit, according to manufacturer instructions (QIAamp
DNA Blood Midi Kit, Qiagen).
Mbl2 promoter and exon 1 polymorphisms (GenBank accession:
rs11003125, rs7096206, rs5030737, rs1800450, rs1800451) have
been genotyped by direct sequencing with the following primers:
50-GCCAGTGGTTTTTGACTCAC-30 and 30-CCTCATATCCCCAGGCAGT-
50, using the Big Dye Terminator kit 3.1 (Applied Biosystems).
Sequencing reactions were run on the ABI 3130 genetic Analyzer
(Applied Biosystems, Foster City, CA, USA); sequenceswere handled
using the 4Peaks (http://mekentosj.com/4peaks/) and Codon-Code
Aligner (http://www.codoncode.com/aligner/) software.
The haplotypes and combined genotypes were computed using
Arlequin version 3.01 software (available at http://cmpg.unibe.ch/
software/arlequin3/) and identiﬁed by a speciﬁc nomenclature,
where the ﬁrst two letters indicate the variants of the promoter re-
gion (‘‘HL’’ and ‘‘XY’’ variants) and the third letter indicates the
combination for the three polymorphisms in exon 1 (‘‘AO’’ variant)
(Garred et al., 1997). The SNP at position +4 has been genotyped
but not considered in this study because of very low relevance in
the variation of serum MBL levels. (Bouwman et al., 2006)2.3. Statistical analysis
Chi-square test was used to verify the Hardy–Weinberg equilib-
rium and the Fisher’s exact test was performed for pair-wise com-
parison of allele, genotype and haplotype frequencies using
contingency tables as appropriate, and only p values <0.05 were
considered as signiﬁcant. All the statistical analyses were carried
out using the open-source R package, (R Development Core Team,
2012) available at http://www.r-project.org site. When calculating
odds ratio (OR) in Tables 1 and 2, the alleles and corresponding
homozygous genotypes with major frequency in the control group
have been selected as reference (OR = 1) and the other ORs have
been presented relative to that reference (Fisher’s exact test,
2  2 contingency tables, degrees of freedom = 1)
Table 1
MBL2 gene polymorphisms frequencies among TB infected subjects (classiﬁed as pulmonary or extra-pulmonary TB) and healthy controls (HC) from Recife, Pernambuco, Brazil.
TB patients Healthy controls
n = 148
p-Value; OR [95%C.I.]
Total
n = 155
Pulmonary
n = 119
Extra-pulmonary
n = 36
Total vs. HC Pulmonary vs. HC Extra-pulmonary
vs. HC
Promoter ‘‘HL’’ variant
Alleles
H 83 (0.27) 61 (0.26) 22 (0.30) 99 (0.33) Ref Ref Ref
L 227 (0.73) 177 (0.74) 50 (0.70) 197 (0.67) 0.076; 1.37 [0.95–1.97] 0.057; 1.45 [0.98–2.17] 0.677; 1.14 [0.63–2.09]
Genotypes
H/H 10 (0.06) 8 (0.07) 2 (0.06) 19 (0.13) Ref Ref Ref
H/L 63 (0.41) 45 (0.38) 18 (0.50) 61 (0.41) 0.148; 1.95 [0.78–5.10] 0.274; 1.74 [0.65–5.0] 0.230; 2.77 [0.57–26.8]
L/L 82 (0.53) 66 (0.55) 16 (0.44) 68 (0.46) 0.068; 2.28 [0.93–5.88] 0.089; 2.29 [0.88–6.49] 0.517; 2.22 [0.45–21.6]
H/L+L/L 145 (0.94) 111 (0.93) 34 (0.94) 129 (0.87) 0.077; 2.13 [0.90–5.32] 0.107; 2.03 [0.83–5.60] 0.378; 2.49 [0.55–23.1]
Promoter ‘‘XY’’ variant
Alleles
Y 251 (0.81) 190 (0.80) 61 (0.85) 252 (0.85) Ref Ref Ref
X 59 (0.19) 48 (0.20) 11 (0.15) 44 (0.15) 0.194; 1.34 [0.85–2.11] 0.108; 1.44 [0.89–2.33] 1; 1.03 [0.45–2.18]
Genotypes
Y/Y 101 (0.65) 75 (0.63) 26 (0.72) 110 (0.74) Ref Ref Ref
Y/X 49 (0.32) 40 (0.34) 9 (0.25) 32 (0.22) 0.069; 1.66 [0.96–2.91] 0.036a; 1.82 [1.02–3.30] 0.661; 1.18 [0.44–2.95]
X/X 5 (0.03) 4 (0.03) 1 (0.03) 6 (0.04) 1; 0.908 [0.21–3.69] 1; 0.977 [0.19–4.28] 1; 0.706 [0.01–6.22]
Y/X+X/X 54 (0.35) 44 (0.37) 10 (0.28) 38 (0.26) 0.104; 1.54 [0.91–2.68] 0.061; 1.69 [0.97–2.96] 0.833; 1.11 [0.43–2.66]
Exon 1 ‘‘AO’’ variant
Alleles
A 239 (0.77) 138 (0.77) 56 (0.78) 250 (0.84) Ref Ref Ref
O 71 (0.23) 55 (0.23) 16 (0.22) 46 (0.16) 0.023a; 1.61 [1.05–2.49] 0.00085a; 2.16 [1.35–3.46] 0.217; 1.55 [0.76–3.03]
Genotypes
A/A 92 (0.60) 71 (0.60) 21 (0.58) 108 (0.73) Ref Ref Ref
A/O 55 (0.35) 41 (0.34) 14 (0.40) 34 (0.23) 0.015a; 1.89 [1.10–3.27] 0.037a; 1.82 [1.02–3.28] 0.087; 2.11 [0.88–4.90]
O/O 8 (0.05) 7 (0.06) 1 (0.02) 6 (0.04) 0.581; 1.56 [0.45–5.67] 0.384; 1.76 [0.48–6.65] 1; 0.858 [0.01–7.66]
A/O + O/O 63 (0.40) 48 (0.40) 15 (0.42) 40 (0.27) 0.029a; 1.73 [1.04–2.89] 0.025a; 1.82 [1.05–3.15] 0.104; 1.92 [0.83–4.35]
OR = odds ratio; C.I. = conﬁdence intervals; Ref = reference.
a Statistically signiﬁcant p-values.
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software (version 3.0.5, http://www.psycho.uni-duesseldorf.de/
abteilungen/aap/gpower3/), post hoc goodness of ﬁt v2 test, with
an ‘‘-error’’ probability of 0.05.
The possible presence of population stratiﬁcation bias has been
gauged according to Lee and Wang (2008), considering MBL2 SNP
frequencies at codon 57 reported by Boldt et al. (2006) for different
Brazilian populations, and incidence rates of TB in Brazil, as reported
by Hijjar et al., 2001.3. Results
The results of MBL2 promoter region and exon 1 genotyping in
TB patients and controls are shown in Table 1. All polymorphisms
were in Hardy–Weinberg equilibrium in both patients and control
groups.
MBL2 promoter ‘‘HL’’ SNP showed no difference in allelic or
genotype frequencies between TB patients globally considered
and healthy controls, as well as between each of the two TB sub-
groups (pulmonary and extra-pulmonary) and controls.
For the promoter ‘‘XY’’ variant, although no differences were
seen in allelic frequencies, the Y/X heterozygous genotype was sig-
niﬁcantly more frequent in pulmonary TB patients than controls,
and associated with increased susceptibility to TB development
(p = 0.036; OR = 1.82; 95% CI = 1.02–3.30).
When MBL2 exon 1 ‘‘AO’’ variants were analyzed, the O allele
was signiﬁcantly more frequent in TB patients in general (23%)
than in healthy controls (16%), and associated with increased sus-
ceptibility to TB development (p = 0.023, OR = 1.61, 95% CI 1.05–
2.49). Also the A/O genotype was more frequent in TB patients than
in healthy controls when considered alone (35% vs. 23%, p = 0.015,
OR = 1.89, 95% CI 1.10–3.27) or in combination with the O/O geno-type (A/O plus O/O p = 0.029, OR = 1.73, 95% CI 1.04–2.89), indicat-
ing an association with susceptibility to TB development.
When the speciﬁc form of TB was considered, we found that the
O allele, A/O and A/O plus O/O genotypes were all signiﬁcantly
more frequent in pulmonary (but not in extra-pulmonary) TB pa-
tients than in controls.
In addition to analyzing the exon 1 polymorphisms at codon 52,
54 and 57 together as O alleles, we then considered the three poly-
morphisms singularly (B–D variant alleles, Table 2). No signiﬁcant
differences were found when we compared the frequencies of
polymorphisms at codons 52 (‘‘AD’’ variant) and 54 (‘‘AB’’ variant)
between TB patients and controls, as well as between pulmonary
and extra-pulmonary TB and controls. The analysis of codon 57
showed that the mutant C allele and the A/C genotype were signif-
icantly more frequent in TB patients than controls and both associ-
ated with an increased risk of TB; the same association was
observed in pulmonary TB patients but not in extra-pulmonary.
The C/C mutant genotype was never found in any of the 155 pa-
tients, and any of the controls (Table 2).
In order to exclude that the association of the 57 C allele might
be due to the confounding effect of a population stratiﬁcation bias,
we evaluated the potential bias in our study, according to the
method described by Lee and Wang (2008). Considering an inci-
dence rate of TB in the Brazilian population variable between 30/
1,00,000 and 92/1,00,000 (Hijjar et al., 2001) and an allelic fre-
quency of codon 57 for the Brazilians ranging from 0.003 to 0.24,
as reported by Boldt et al. (2006), the potential confounding rate
ratio (U) was 2.49, which is less than the OR we found for the co-
don 57 SNP (OR = 2.74). This indicates that the association found
between MBL2 codon 57 SNP and TB cannot be ascribable to pop-
ulation stratiﬁcation bias alone.
We also considered the MBL2 combined promoter and exon 1
genotypes, classiﬁed according to Bouwman et al. (2006) as high
Table 2
MBL2 Exon 1 gene polymorphisms (at codons 52, 54 and 57) frequencies among TB infected subjects (classiﬁed as pulmonary or extra-pulmonary TB) and healthy controls (HC)
from Recife, Pernambuco, Brazil.
TB patients Healthy controls
n = 148
p-Value; OR [95%C.I.]
Total
n = 155
Pulmonary
n = 119
Extra-pulmonary
n = 36
Total vs. HC Pulmonary vs. HC Extra-pulmonary
vs. HC
Codon 52 ‘‘AD’’ variant
Alleles
A 296 (0.95) 226 (0.95) 70 (0.97) 285 (0.96) Ref Ref Ref
D 14 (0.05) 12 (0.05) 2 (0.03) 11 (0.04) 0.685; 1.22 [0.50–3.03] 0.522; 1.37 [0.54–3.50] 1; 0.74 [0.07–3.51]
Genotypes
A/A 142 (0.91) 108 (0.91) 34 (0.94) 138 (0.93) Ref Ref Ref
A/D 12 (0.08) 10 (0.08) 2 (0.06) 9 (0.06) 0.653; 1.29 [0.48–3.59] 0.482; 1.41 [0.49–4.09] 1; 0.902 [0.09–4.65]
D/D 1 (0.01) 1 (0.01) 0 (0) 1 (0.01) 1; 0.971 [0.01–76.78] 1; 1.27; [0.01–100.9] 1; 0 [0.0–159.4]
A/D+D/D 13 (0.09) 11 (0.09) 2 (0.06) 10 (0.07) 0.667; 1.26 [0.49–3.33] 0.498; 1.40 [0.51–3.83] 1; 0.812 [0.08–4.07]
Codon 54 ‘‘AB’’ variant
Alleles
A 275 (0.89) 212 (0.90) 63 (0.88) 269 (0.91) Ref Ref Ref
B 35 (0.11) 26 (0.10) 9 (0.12) 27 (0.09) 0.422; 1.26 [0.72–2.24] 0.560; 1.22 [0.66–2.24] 0.380; 1.42 [0.55–3.30]
Genotypes
A/A 122 (0.79) 95 (0.80) 27 (0.75) 124 (0.84) Ref Ref Ref
A/B 31 (0.20) 22 (0.18) 9 (0.25) 21 (0.14) 0.226; 1.49 [0.78–2.90] 0.402; 1.36 [0.67–2.78] 0.138; 1.95 [0.70–5.08]
B/B 2 (0.01) 2 (0.02) 0 (0) 3 (0.02) 1; 0.678 [0.05–6.03] 1; 0.870 [0.07–7.75] 1; 0 [0.0–11.57]
A/B+B/B 33 (0.21) 24 (0.20) 9 (0.25) 24 (0.16) 0.303; 1.39 [0.75–2.62] 0.426; 1.30 [0.66–2.56] 0.230; 1.71 [0.62–4.37]
Codon 57 ‘‘AC’’ variant
Alleles
A 288 (0.93) 221 (0.93) 67 (0.93) 288 (0.97) Ref Ref Ref
C 22 (0.07) 17 (0.07) 5 (0.07) 8 (0.03) 0.014a; 2.74 [1.15–7.25] 0.021a; 2.76 [1.10–7.54] 0.144; 2.67 [0.66–9.62]
Genotypes
A/A 133 (0.86) 102 (0.93) 31 (0.86) 140 (0.95) Ref Ref Ref
A/C 22 (0.14) 17 (0.07) 5 (0.14) 8 (0.05) 0.012a; 2.88 [1.18–7.76] 0.018a; 2.90 [1.13–8.09] 0.137; 2.80 0.67–10.51
C/C 0 (0) 0 (0) 0 (0) 0 (0.00) 1; 0 [0.0–Inf] 1; 0 [0.0–Inf] 1; 0 [0.0–Inf]
A/C+C/C 22 (0.14) 17 (0.07) 5 (0.14) 8 (0.05) 0.012a; 2.88 [1.18–7.76] 0.018a; 2.90 [1.13–8.09] 0.137; 2.80 0.67–10.51
OR = odds ratio; C.I. = conﬁdence intervals; Ref = reference.
a Statistically signiﬁcant p-values.
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low producers (LXA/LXA, HYA/O, and LYA/O), and deﬁcient produc-
ers (LXA/O and O/O) (Table 3): no statistical differences in the fre-
quencies were observed between the analyzed groups.
Finally, we calculated the statistical power: our study has a
power >95% (with 5% conﬁdence) to detect a medium or large ef-
fect size (w = 0.3 or w = 0.05) for MBL2 genotypes in overall or pul-
monary/extrapulmonary TB susceptibility. Assuming a lower effect
size (w < 0.2 or w < 0.1), the power decreases (<80% and <30%,
respectively) indicating that the present study may have failed,
due to a type II error to detect small effects (i.e. false negative).4. Discussion
Host genetic factors can determine differences in the suscepti-
bility and/or resistance to infections, as well as in the clinical pat-
terns of diseases. In our study we showed that MBL2 ‘‘XY’’
promoter polymorphism and the ‘‘AC’’ polymorphism at codon
57 are involved in the susceptibility to TB development in a north-
eastern Brazilian population. A signiﬁcant association was found
for MBL2 C allele and A/C genotype at codon 57, and for the Y/X
promoter genotype, with the pulmonary but not extrapulmonary
form of TB disease.
So, we can assume that there is no association between the
presence of these variations and the development of extra-pul-
monary TB and that MBL2 variant can inﬂuence the risk only of
the pulmonary form; however, since MBL2 frequencies were not
signiﬁcantly different between pulmonary and extra-pulmonary
TB patients, the lack of association in the extra-pulmonary group
could be due to the small sample size of this group (36 patients).
Calculations of statistical power indicate that our study, althoughhaving a power >95% to detect a medium/large effect ofMBL2 vari-
ants in TB, may have instead failed to detect a smaller effect (power
<30% for w = 0.01).
Mbl2 polymorphisms have been associated with low levels of
MBL in serum. Individuals homozygous forMBL2mutation have al-
most undetectable levels of MBL (610 ng/ml); average levels are
reduced to approximately 350 ng/ml in heterozygotes, while MBL
concentration reaches over 1600 ng/ml in wild type homozygous
individuals (Davies et al., 2001). The decrease in concentration of
circulating MBL has been associated with recurrent infections in
childhood and possibly in adults. However, the effect of low MBL
levels on TB has been controversial: some studies reported low
MBL levels as associated with protection against the disease,
whereas others estimated a relation with increased susceptibility
(Denholm et al., 2010).
Alagarasu et al. (2007) and Selvaraj et al. (2006), have previ-
ously suggested that O/O genotype may be associated with suscep-
tibility to TB, since they observed a signiﬁcant increase in the
frequency of O/O genotype in TB patients than controls. Addition-
ally, Capparelli et al. (2009), reported higher frequencies of the O/O
genotype among patients (22.3% vs. 3.5%in controls) in an Italian
population. In our study, the O/O genotype frequency distribution
was similar between patients and controls, but the O allele, as well
as the A/O genotype, were signiﬁcantly more frequent in TB pa-
tients, (pulmonary TB), than healthy controls; the homozygous A/
A genotype, responsible for higher levels of circulating MBL pro-
teins, was more frequent in controls than in TB patients. These data
indicate a possible protective effect of medium/high levels of MBL
toward TB infection.
On other hand, some studies have shown that MBL deﬁciency
protects against disease caused by M. tuberculosis (Garcia-Laorden
et al., 2006; Cosar et al., 2008; Denholm et al., 2010; Liu et al.,
Table 3
MBL2 combined genotypes frequencied in TB infected subjects (classiﬁed as pulmonary or extrapulmonary TB) and healthy controls (HC) from Recife, Pernambuco, Brazil.
MBL2 combined genotypes TB Patients Healthy controls
n = 148
p-Value; OR [95% C.I.]
Total
n = 155
Pulmonary
n = 119
Extra-pulmonary
n = 36
Total vs. HC Pulmonary vs. HC Extra-pulmonary
vs. HC
High production (HP)
HYA/HYA
HYA/LYA
HYA/LXA 88 (0.57) 67 (0.56) 21 (0.58) 92 (0.62) Ref Ref Ref
LYA/LYA
LYA/LXA
Low production (LP)
LXA/LXA
HYA/O 58 (0.37) 45 (0.38) 13 (0.36) 44 (0.30) 0.216; 1.37 [0.82–2.31] 0.231; 1.40 [0.80–2.44] 0.545; 1.29 [0.54–2.99]
LYA/O
Deﬁcient production (DP)
LXA/O 9 (0.06) 7 (0.06) 2 (0.06) 12 (0.08) 0.650; 0.785 [0.27–2.14] 0.806; 0.801 [0.25–2.34] 1; 0.73 [0.07–3.68]
O/O
OR = odds ratio; C.I. = conﬁdence intervals; Ref = reference.
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Gambian children (Bellamy et al., 1998) and South African adults
(Hoal-Van Helden et al., 1999), or full promoter haplotypes respon-
sible for low MBL production, have been shown to be protective
against tuberculosis. Søborg et al. (2003) demonstrated a signiﬁ-
cantly decreased frequency of individuals with the low-expressing
MBL genotype in Caucasian patients compared to control subjects.
The same tendency was also observed in patients of other ethnic
origin. The authors hypothesized that heterozygosity forMBL2 var-
iant alleles, responsible for low serum MBL levels, was associated
with protection against clinical TB. Studies in Danish patients
(Søborg et al., 2003) and Turkish children (Solg˘un et al., 2011)
showed no association between MBL2 polymorphisms at the co-
dons 54 and 57 and susceptibility to pediatric TB.
There is no doubt about the difﬁculty in comparing results from
studies conducted in different populations, even when the same al-
lele or haplotype are analyzed and the same study design is used.
In addition to this, several studies investigated the role of MBL in
TB in the context of HIV co-infection and thus with the confound-
ing aspect of immunosuppression. As reported in the methods sec-
tion we decided to eliminate this bias excluding patients with HIV
co-infection form our study. Since the frequency ofMBL2 polymor-
phism, as well as the incidence rates of tuberculosis, are know to
vary among different populations, it is not excluded that some of
the discrepant ﬁndings could be due, at least in part, to the differ-
ent ethnicity of the subjects involved. The gene pool can greatly af-
fect the results of an association study (El Sahly et al., 2004), so that
investigations in homogeneous populations are preferred. In north-
eastern Brazilian population, African, Caucasian and Native Amer-
ican genetic contributions may have resulted in a different
distribution of MBL2 polymorphisms when compared with other
populations.
In a recent study, Araújo et al. (2012) have studied the ‘‘AO’’
MBL2 variant in TB patients (pulmonary and extra-pulmonary)
and healthy controls in a population from the Amazon region
(Northern of Brazil), without ﬁnding any evidence of association
between this polymorphism and TB. Despite both populations
(our from Recife and the one from Belém do Pará studied by Araújo
et al. (2012)) are from Brazil, there are considerable differences in
their ethnic composition. Alves-Silva et al. (2000) had shown, by
studying the mitochondrial genome of different regions of Brazil,
that the Northern population (Belém do Pará) is a combined mix-
ture of the genome of Native Americans (54%), Africans (15%)
and Europeans (31%), while the Northeastern population is com-
prised of 22% Native American, 44% African and 34% European gen-omes. The fact that MBL2 ‘‘AO’’ polymorphism frequencies are
signiﬁcantly different between the controls in our study and those
of Araújo et al., conﬁrm the different ethnicity of the two groups
considered in the two studies.
When considering a heterogeneous population such as the Bra-
zilian one, population stratiﬁcation represents a possible bias that
should be taken into account. Nonetheless, we don’t think that our
results, evidencing an association ofMBL2 codon 57 with tubercuo-
losis could be due exclusively to a type I error (i.e. false positive),
for several reasons. Firstly, as indicated by Wacholder et al.
(2000), population stratiﬁcation bias will decrease as the number
of ethnic strata increases; the Northeast Brazilian population (Re-
cife) analyzed in this study, comprised at least three strata, Europe-
ans, Africans, and Native Americans (from different tribes,
increasing even more the number of strata). Moreover, as shown
by both Khlat et al. (2004) and Pritchard and Donnelly (2001),
the extent of bias caused by population stratiﬁcation increases as
the samples size becomes larger, due to the greater power to detect
both real association and spurious ones. Once again, this is not the
case with our study, since the number of samples analyzed (155
cases and 148 controls) can be considered of moderate size. Finally,
by using in our study the formula described by Lee and Wang
(2008) in order to gauge the potential impact of population strati-
ﬁcation bias, we evidenced that the estimated potential bias
(U = 2.49) was, although slightly, below the estimated OR for
MBL2 codon 57 polymorphism, thus suggesting that our ﬁndings
cannot be explained by the population stratiﬁcation bias alone.
It is also worth to consider that TB is a multifactorial disease
and its susceptibility depends not only upon host genetic aspects,
but also on mycobacteria characteristics and on interactions with
environmental factors. In a work, performed on Ghanaian patients,
Thye et al. (2011) found that MBL2 low-producer haplotype LYQC
(including the structural C variant at codon 57) was associated,
in a recessive mode of inheritance, with protection from TB caused
by Mycobacterium africanum/Mycobacterium bovis but not from TB
caused byM. tuberculosis. Moreover, allM. africanum isolates tested
in their study bound recombinant human MBL to a greater extent
than did M. tuberculosis isolates. The authors thus suggest that
binding of MBL to mycobacteria may mediate phagocytosis by
their target cell, the macrophage, and thus a decreased concentra-
tion and a functional impairment of MBL caused by mutations of
the LYQC haplotype might reduce phagocytosis of mycobacteria
by macrophages; a reduced uptake by macrophages could be one
of the events that contribute to resistance against TB. However,
this last observation was made in a mouse model that, as the
328 H.L.A. da Cruz et al. / Infection, Genetics and Evolution 19 (2013) 323–329authors admit, is not directly valid in human disease. Thye et al.
ﬁndings are in contrast with our results, indicating association of
MBL2 SNP at codon 57 with TB susceptibility. Once again, allele C
frequencies are quite different between our population and Ghana-
ian, and moreover we don’t exactly know to what extent our pa-
tients were infected by M. africanum or M. tuberculosis isolates.
The putative protective MBL2 haplotype LYQC, which is virtually
unique to sub-Saharan Africa and occurs there at high frequencies,
might have been selected because it confers protection from clini-
cal TB caused by M. africanum/M. bovis. The pattern of variation in
the gene may represent a past adaptation to pathogens, with selec-
tion maintaining polymorphisms that optimized the ﬁtness of the
carriers in these environments. Widespread and ancient diseases
such as tuberculosis, were found to be negatively associated with
the MBL2 ‘‘low-secretor haplotypes’’ and protection against these
diseases has been taken as evidence for the hypothesis that natural
selection drove these MBL2 haplotypes to their actual high fre-
quency. It is possible, as suggested by Boldt et al. (2006) that sto-
chastic evolutionary factors erased much of the ancient imprint
left by natural selection forMBL2 on the regional scale, for example
in Amerindian populations.
We also have to acknowledge that most of the signiﬁcant p-val-
ues presented in our study are slightly within the statistically sig-
niﬁcant threshold and after application of Bonferroni’s correction
for multiple tests, the statistical signiﬁcance will be lost. However,
it is known that applying standard methods of correction for multi-
ple tests, such as Bonferroni’s adjustment can be very conservative
andmay be too stringent, probably not recognizing the small single
effect such as those expected for a single gene in complex diseases.
For this reason, we preferred to avoid setting rigorous limits in or-
der to highlight the possible association between MBL2 and TB, an
association that will have to be further investigated and conﬁrmed
by other studies as well as in different populations.
All this considered, although our study suggests thatMBL2 poly-
morphisms may be associated with susceptibility to pulmonary TB
development in Brazilian, further investigation and replica studies
are needed in order to disclose MBL role in tuberculosis.Acknowledgments
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